Aion As announced that it has entered into an investment agreement to raise NOK 40 million in a round of funding on June 14, 2022. The transaction will include participation from new investor Ocean 14 Capital Ltd. and existing investor Aker BioMarine AS for NOK 20 million each. The company will issue unsecured convertible loan facility in the transaction.

The round will be raised at a pre-money valuation of EUR 9.5 million (NOK 98.86194 million). Conversion shall take place upon a subsequent capital raise from external investors. After conversion, Aker BioMarine AS is expected to own around 85% of the shares in the company.

Furthermore, Ocean 14 Capital will take operational control and have both a majority of the voting rights and board representatives in the company towards the next financing phase.